BioNano Genomics Inc vs Ishares Msci Spain ETF — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while Ishares Msci Spain ETF trades at $62.71. The key difference: Ishares Msci Spain ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | EWP | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $4.92 | $62.66 |
52-Week Low | $1.06 | $47.02 |
Enterprise Value | $16.26M | — |
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
EWP trades at $62.76, up 0.56% with strong technical momentum as moving averages signal bullish alignment. The stock shows mixed oscillators with RSI indicating potential overbought conditions. Recent corporate actions include a $0.92 dividend scheduled for June 2026, providing income appeal to investors.
The bullish technical setup suggests near-term upside potential, though overbought RSI levels warrant caution. European market strength and ECB policy stability create favorable conditions, but reliance on macroeconomic factors rather than company-specific fundamentals presents concentration risk for US investors.
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →